clinical trial · NCT04489381
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Romark Laboratories L.C.·phase3·terminated·n = 214
EnterovirusRhinovirusNitazoxanidePlaceboVitamin Super B-Complex
brief summary
Trial to evaluate the efficacy and safety of nitazoxanide in the treatment of colds due to enterovirus/rhinovirus infection
started
Aug 19, 2020
primary completion
Jan 28, 2021
completion
Feb 2, 2021
last updated
Oct 17, 2024
detailed description
Multicenter, randomized, double-blind trial to evaluate the efficacy and safety of nitazoxanide in the treatment of colds due to enterovirus/rhinovirus infection
official title
Phase 3, A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol